These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9810200)

  • 1. [Manufacturing of cidofovir for intravitreal injections in cytomegalovirus retinitis].
    Mucci M
    Rev Med Suisse Romande; 1998 Sep; 118(9):819-20. PubMed ID: 9810200
    [No Abstract]   [Full Text] [Related]  

  • 2. [Fabrication of cidofovir ampules for intravitreal injections for cytomegalovirus retinitis].
    Schleppy CA; Tritten JJ
    Rev Med Suisse Romande; 1998 Mar; 118(3):263-5. PubMed ID: 9594603
    [No Abstract]   [Full Text] [Related]  

  • 3. New developments in the treatment of CMV retinitis.
    Freeman WR
    Ophthalmology; 1996 Jul; 103(7):999-1000. PubMed ID: 8684813
    [No Abstract]   [Full Text] [Related]  

  • 4. Low-dose intravitreal cidofovir (HPMPC) therapy of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome.
    Taskintuna I; Rahhal FM; Arevalo JF; Munguia D; Banker AS; De Clercq E; Freeman WR
    Ophthalmology; 1997 Jun; 104(6):1049-57. PubMed ID: 9186448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I/II study of intravitreal cidofovir for the treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome.
    Kirsch LS; Arevalo JF; De Clercq E; Chavez de la Paz E; Munguia D; Garcia R; Freeman WR
    Am J Ophthalmol; 1995 Apr; 119(4):466-76. PubMed ID: 7709971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intravitreal injection of cidofovir in cytomegalovirus retinitis].
    Kersten A; Althaus C; Hudde T; Pascha G; Schweykart N; Sundmacher R
    Ophthalmologe; 1998 Sep; 95(9):602-6. PubMed ID: 9793381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal cidofovir for the maintenance treatment of cytomegalovirus retinitis.
    Rahhal FM; Arevalo JF; Munguia D; Taskintuna I; Chavez de la Paz E; Azen SP; Freeman WR
    Ophthalmology; 1996 Jul; 103(7):1078-83. PubMed ID: 8684797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution and metabolism of intravitreal cidofovir and cyclic HPMPC in rabbits.
    Cundy KC; Lynch G; Shaw JP; Hitchcock MJ; Lee WA
    Curr Eye Res; 1996 May; 15(5):569-76. PubMed ID: 8670758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystoid macular edema following immune recovery and treatment with cidofovir for cytomegalovirus retinitis.
    Kersten AJ; Althaus C; Best J; Sundmacher R
    Graefes Arch Clin Exp Ophthalmol; 1999 Nov; 237(11):893-6. PubMed ID: 10541898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous cidofovir-induced iritis.
    Neau D; Renaud-Rougier MB; Viallard JE; Dutronc H; Cazorla C; Ragnaud JM; Dupon M; Lacut JY
    Clin Infect Dis; 1999 Jan; 28(1):156-7. PubMed ID: 10028099
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypotony after intravenous cidofovir therapy for the treatment of cytomegalovirus retinitis.
    Wang L; Damji KF; Chialant D; Hodge WG
    Can J Ophthalmol; 2002 Dec; 37(7):419-22. PubMed ID: 12516724
    [No Abstract]   [Full Text] [Related]  

  • 12. Recurrent iritis after intravenous administration of cidofovir.
    Palau LA; Tufty GT; Pankey GA
    Clin Infect Dis; 1997 Aug; 25(2):337-8. PubMed ID: 9332544
    [No Abstract]   [Full Text] [Related]  

  • 13. AIDS therapy. New hope against blindness.
    Cohen J
    Science; 1995 Apr; 268(5209):368-9. PubMed ID: 7716538
    [No Abstract]   [Full Text] [Related]  

  • 14. Cidofovir approved.
    PI Perspect; 1996 Sep; (No 19):14-5. PubMed ID: 11363898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cidofovir in the treatment of cytomegalovirus (CMV) retinitis.
    Garcia CR; Torriani FJ; Freeman WR
    Ocul Immunol Inflamm; 1998 Sep; 6(3):195-203. PubMed ID: 9785611
    [No Abstract]   [Full Text] [Related]  

  • 16. Liposome-encapsulated (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine for long-acting therapy of viral retinitis.
    Kuppermann BD; Assil KK; Vuong C; Besen G; Wiley CA; De Clercq E; Bergeron-Lynn G; Connor JD; Pursley M; Munguia D; Freeman WR
    J Infect Dis; 1996 Jan; 173(1):18-23. PubMed ID: 8537656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse events and autopsy findings after intravitreous cidofovir (HPMPC) therapy in patients with acquired immune deficiency syndrome (AIDS).
    Taskintuna I; Rahhal FM; Rao NA; Wiley CA; Mueller AJ; Banker AS; De Clercq E; Arevalo JF; Freeman WR
    Ophthalmology; 1997 Nov; 104(11):1827-36; discussion 1836-7. PubMed ID: 9373113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypotony and visual loss with intravenous cidofovir treatment of cytomegalovirus retinitis.
    Friedberg DN
    Arch Ophthalmol; 1997 Jun; 115(6):801-2. PubMed ID: 9194736
    [No Abstract]   [Full Text] [Related]  

  • 19. [Ocular complications of the virostatic drug cidofovir].
    Hackethal U; Holzapfel C; Gerding H; Husstedt IW
    Klin Monbl Augenheilkd; 2003 Jun; 220(6):391-5. PubMed ID: 12830392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local therapy for cytomegalovirus retinitis.
    Smith CL
    Ann Pharmacother; 1998 Feb; 32(2):248-55. PubMed ID: 9496411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.